Home / Companies / Jointown Pharmaceutical Group Co., Ltd. / 19 Sep 2023
Jointown Pharmaceutical Group Co., Ltd.: meeting of 19 Sep 2023
Votes reported on Form N-PX, item by item
45 Form N-PX filers reported votes at the Jointown Pharmaceutical Group Co., Ltd. meeting of 19 Sep 2023. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
73 vote records from 45 filers. 7 of the 45 filers that marked the item either way voted against management.
EXTRAORDINARY TRANSACTIONSIssuer
EXTRAORDINARY TRANSACTIONS: management items
Management items in this category are shown together; filers word and number them differently.
16 vote records from 6 filers. 0 of the 6 filers that marked the item either way voted against management.
CAPITAL STRUCTUREIssuer
CAPITAL STRUCTURE: management items
Management items in this category are shown together; filers word and number them differently.
276 vote records from 45 filers. 3 of the 45 filers that marked the item either way voted against management.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
73 vote records from 45 filers. 0 of the 45 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Auditor |
|---|---|
| Vanguard | For |
| BlackRock and iShares | For |
| Fidelity | For |
| Dimensional | For |
| State Street and SPDR | For |
| Franklin Templeton | Against * |
| Charles Schwab | Against * |
| Nuveen and TIAA | For |
| John Hancock and Manulife | For |
| Morgan Stanley, Eaton Vance and Calvert | For |
| J.P. Morgan | For |
| Goldman Sachs | For |
| PGIM and Prudential | For |
| Jackson National funds | For |
| Northern Trust and FlexShares | For |
| SEI | Against * |
| Thrivent | For |
| Lincoln Financial | For |
| Nationwide | For |
| Brighthouse Funds | For |
| Pacific Life funds | For |
| Global X | Against * |
| AllianceBernstein | Against * |
| PIMCO | For |
| Allspring | For |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Jointown Pharmaceutical Group Co., Ltd. meeting?
45 Form N-PX filers reported votes at the meeting of 19 Sep 2023. The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Jointown Pharmaceutical Group Co., Ltd. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Jointown Pharmaceutical Group Co., Ltd.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Jointown Pharmaceutical Group Co., Ltd. with a meeting date within three days of 19 Sep 2023. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.